OWC Pharmaceutical Research Corp (OWCP)

[stockseekerok]

One World Cannabis Files 6th Provisional Patent Application With USPTO
Mar 24, 2015

OTC Disclosure & News Service

-
One World Cannabis Files 6th Provisional Patent Application With USPTO

PR Newswire

PETACH TIKVA, Israel, March 24, 2015

PETACH TIKVA, Israel, March 24, 2015 /PRNewswire/ --

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), an Israel-based developer of cannabinoid-based therapies targeting a variety of different indications, today announced that its wholly owned subsidiary, One World Cannabis Ltd. ("the Company"), had their sixth provisional application filled with the USPTO.

(Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )

(Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )

The latest provisional application relates to novel compositions and methods for the administration of pharmaceutical formulations. More specifically, the current invention pertains to an emulsion comprised of enriched concentrations of Tetrahydrocannabinol ("THC"), Cannabidiol ("CBD") or derivatives thereof that may be useful as a novel delivery method for the treatment of various medical conditions.

"This provisional patent application protects key intellectual property relating to unique formulations and specific delivery systems for cannabinoid-based therapies," said One World Cannabis CEO Mr. Ziv Turner. "We plan to continue to file additional patent applications covering our ideas and novel solutions to ultimately pave the way for our breakthrough technologies and drive long-term shareholder value."

About One World Cannabis Ltd.

One World Cannabis Ltd. ("the Company") is an Israel-based company founded in 2014 by a group of professionals with expertise in the field of medical cannabis (marijuana) treatment and medical cannabis regulatory affairs. The Company's Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids in the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks. The Company is a wholly owned subsidiary of OWC Pharmaceutical Research Corp. (OTCQB: OWCP).